Log In
Print this Print this

Liposomal adenosylcobalamin (Lipo-AdCbl) (HL009)

  Manage Alerts
Collapse Summary General Information
Company HanAll Biopharma Co. Ltd.
DescriptionTopical formulation of liposomal adenocylcobalamin
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationDermatitis
Indication DetailsTreat atopic dermatitis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today